Christoph Röllig

87PUBLICATIONS
453CO-AUTHORS
HaematologyEpigenetics (incl. genome methylation and epigenomics)Predictive and prognostic markersMedical infection agents (incl. prions)Liquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (87)

|Jul 19, 2026
Eltrombopag Added to Standard Immunosuppressive Treatment as Front-Line Therapy for Severe Aplastic Anemia: Long-Term Outcomes of the Phase-3 Randomized Superiority EBMT-SAAWP RACE Study.

|Jun 25, 2026
Genomic landscape of acute myeloid leukemia in adolescents and young adults.

|Jun 23, 2026
Prognostic impact of intensive chemotherapy in patients with TP53-mutated AML.

|May 21, 2026
Prognostic impact of FLT3-ITD microclones in young adults with acute myeloid leukemia treated with intensive chemotherapy.

|May 12, 2026
Comprehensive mutational profiling and clinical outcome of adult acute myeloid leukemia patients with NUP98 rearrangement.

|Apr 06, 2026
Phase 1 Study of KITE-222, an Autologous CLL-1-Directed CAR T-cell Therapy in Patients with Relapsed/Refractory Acute Myeloid Leukemia.

Naval Daver, James S Blachly, Armin Ghobadi

Pageof 15

Frequent Collaborators

29 joint publications

Sarah Bertoli

15 joint publications

Pierre-Yves Dumas

15 joint publications

François Vergez

15 joint publications

Eric Delabesse